These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30695322)

  • 1. [New Insights into Diagnosis and Pathogenesis of Amyloidosis by Mass Spectrometric Analysis].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2016 Jun; 64(6):675-679. PubMed ID: 30695322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.
    Gilbertson JA; Theis JD; Vrana JA; Lachmann H; Wechalekar A; Whelan C; Hawkins PN; Dogan A; Gillmore JD
    J Clin Pathol; 2015 Apr; 68(4):314-7. PubMed ID: 25637636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
    Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
    Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in protein misfolding diseases.
    Stoppini M; Obici L; Lavatelli F; Giorgetti S; Marchese L; Moratti R; Bellotti V; Merlini G
    Clin Chem Lab Med; 2009; 47(6):627-35. PubMed ID: 19527136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Adnexal Amyloidosis: A Mass Spectrometric Analysis.
    Blandford AD; Yordi S; Kapoor S; Yeaney G; Cotta CV; Valent J; Perry JD; Singh AD
    Am J Ophthalmol; 2018 Sep; 193():28-32. PubMed ID: 29890159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
    Lim A; Wally J; Walsh MT; Skinner M; Costello CE
    Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirming the Diagnosis of Amyloidosis.
    Wisniowski B; Wechalekar A
    Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of systemic amyloid deposits by mass spectrometry.
    Murphy CL; Wang S; Williams T; Weiss DT; Solomon A
    Methods Enzymol; 2006; 412():48-62. PubMed ID: 17046651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to diagnose amyloidosis.
    Mollee P; Renaut P; Gottlieb D; Goodman H
    Intern Med J; 2014 Jan; 44(1):7-17. PubMed ID: 24024789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis: Insights from Proteomics.
    Dogan A
    Annu Rev Pathol; 2017 Jan; 12():277-304. PubMed ID: 27959636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of amyloid fibril precursors in renal tissue.
    Wagrowska-Danilewicz M; Danilewicz M
    Acta Histochem; 1996 Jul; 98(3):301-8. PubMed ID: 8863859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
    Lavatelli F; Perlman DH; Spencer B; Prokaeva T; McComb ME; Théberge R; Connors LH; Bellotti V; Seldin DC; Merlini G; Skinner M; Costello CE
    Mol Cell Proteomics; 2008 Aug; 7(8):1570-83. PubMed ID: 18474516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.